Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Photo gallery: With a Boulevard in hand, Techweek pours into KC
Hundreds of techies, innovators and entrepreneurs converged in Kansas City for the third annual Techweek KC conference, which launched Monday and runs through Friday. The Chicago-based conference series, which focuses on innovation and entrepreneurship, returned to the City of Fountains for a five-day conference, expo and festival. It is one of nine such events across…
Greitens eyes private investment dollars to fill MTC budget gap
A new, privately-managed innovation fund could replace a popular startup investment program that was dramatically slashed for 2018 amid Missouri’s budget crunch. The potential strategy change comes as a suggestion from the Hawthorn Foundation’s report to Missouri Gov. Eric Greitens, following the months-long work of an innovation task force charged with assessing the current state…
Prospect to prosperity: Blue Hills boosting neighborhood entrepreneurs (Video)
Economic development along Prospect Avenue requires a chain reaction across the community, Edgar Palacios said. “People need jobs to afford homes, so we need to create those jobs. We need to create some catalysts in this community,” said Palacios, Blue Hills Community Services executive director. “If we can have storefronts along Prospect, that attracts other…
10 BetaBlox firms to know before demo day
Kansas City-based accelerator BetaBlox announced the 10 companies pitching their companies during the program’s Sept. 23 demo day at The GRID. BetaBlox recently received a grant from the Ewing Marion Kauffman Foundation, as part of the KC Accelerator challenge. The 2017 demo day is sponsored by the foundation, BetaBlox founder Wes Bergmann said. This year’s…